Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update
Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter ended December 31, 2022
By AP News
Published - Mar 02, 2023, 05:36 PM ET
Last Updated - Apr 03, 2024, 03:38 PM EDT
—Announced proposed merger with Cibus Global and filed initial registration statement on Form S-4—
—Current customer projects under development are on track—
—Signed agreement with Evologic Technologies to further develop and scale production of its Plant Cell Matrix™ and BioFactoryTM technologies—
ROSEVILLE, Minn., March 2, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter ended December 31, 2022.